InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by Berger Dietmar. Director active across 1 company, notably Gilead Sciences, INC.. Cumulatively, 7 filings have been logged. Activity tracked since 27 February 2026. The latest transaction was disclosed on 10 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Berger Dietmar is a declarant linked to Gilead Sciences, INC., where the listed role is Chief Medical Officer. The record shows 5 filings in total, with 5 sampled filings between 2026-01-05 and 2026-06-11, and the most common transaction nature is option exercise.